These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7628087)

  • 1. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure.
    Jackson P; Loughrey CM; Lightbody JH; McNamee PT; Young IS
    Clin Chem; 1995 Aug; 41(8 Pt 1):1135-8. PubMed ID: 7628087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global assessment of serum antioxidant status in hemodialysis patients.
    Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
    J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure.
    Ha TK; Sattar N; Talwar D; Cooney J; Simpson K; O'Reilly DS; Lean ME
    QJM; 1996 Oct; 89(10):765-9. PubMed ID: 8944232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
    Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B
    Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant status and lipid peroxidation in hereditary haemochromatosis.
    Young IS; Trouton TG; Torney JJ; McMaster D; Callender ME; Trimble ER
    Free Radic Biol Med; 1994 Mar; 16(3):393-7. PubMed ID: 8063202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
    Clermont G; Lecour S; Lahet J; Siohan P; Vergely C; Chevet D; Rifle G; Rochette L
    Cardiovasc Res; 2000 Aug; 47(3):618-23. PubMed ID: 10963735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus.
    Maxwell SR; Thomason H; Sandler D; Leguen C; Baxter MA; Thorpe GH; Jones AF; Barnett AH
    Eur J Clin Invest; 1997 Jun; 27(6):484-90. PubMed ID: 9229228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men.
    Nyyssönen K; Porkkala-Sarataho E; Kaikkonen J; Salonen JT
    Atherosclerosis; 1997 Apr; 130(1-2):223-33. PubMed ID: 9126668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol and urate levels.
    Severin E; Nave B; Ständer M; Ott R; Traupe H
    Dermatology; 1999; 198(4):336-9. PubMed ID: 10449930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.
    Wittenstein B; Klein M; Finckh B; Ullrich K; Kohlschütter A
    Free Radic Biol Med; 2002 Jul; 33(1):103-10. PubMed ID: 12086688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis.
    Langley SC; Brown RK; Kelly FJ
    Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals.
    Soriani M; Pietraforte D; Minetti M
    Arch Biochem Biophys; 1994 Jul; 312(1):180-8. PubMed ID: 8031126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for alterations in circulating low-molecular-weight antioxidants and increased lipid peroxidation in smokers on hemodialysis.
    Lim PS; Wang NP; Lu TC; Wang TH; Hsu WM; Chan EC; Hung WR; Yang CC; Kuo IF; Wei YH
    Nephron; 2001 Jun; 88(2):127-33. PubMed ID: 11399914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is associated with alterations of blood thiol-group related antioxidants in patients on hemodialysis.
    Wang NP; Lim PS; Chen TT; Thien LM; Wang TH; Hsu WM
    Nephron; 2002 Dec; 92(4):772-9. PubMed ID: 12399620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total radical-trapping antioxidant parameter in NIDDM patients.
    Ceriello A; Bortolotti N; Falleti E; Taboga C; Tonutti L; Crescentini A; Motz E; Lizzio S; Russo A; Bartoli E
    Diabetes Care; 1997 Feb; 20(2):194-7. PubMed ID: 9118773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbate is an outstanding antioxidant in human blood plasma.
    Frei B; England L; Ames BN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6377-81. PubMed ID: 2762330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
    Montazerifar F; Hashemi M; Karajibani M; Dikshit M
    J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antioxidant defense in actinic keratosis and basal cell carcinoma.
    Vural P; Canbaz M; Selçuki D
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):96-101. PubMed ID: 10568487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Homeostasis of antioxidant status in hemodialysis patients].
    Saionji K; Sato T; Higurashi H; Iizuka K
    Rinsho Byori; 1999 May; 47(5):461-6. PubMed ID: 10375968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.